This proposal is directed toward the mechanism(s) of thromboembolic complications caused by biologic agents, such as disseminated intravascular coagulation, which contributes to the mortality of patients with sepsis due to endotoxin-producing bacteria, and to patients with staphylococcal infections such as Toxic Shock Syndrome. We plan to investigate the cellular and molecular pathology of endotoxin's action toward human target cells includeing platelets and endothelial cells. Since Lipid A is responsible for the interaction of endotoxin with human platelets, we plan to focus our effort on determining the molecular basis for Lipid A action on the cell membrane of human cells. We will use isotope tracer, immunological and enzymatic analysis to determine the binding of Lipid A to platelets and endothelial cells, and functional changes in their membranes. We will investigate the mechanism of action of staphylococcal products on the blood clotting system with emphasis on changes in the Fc receptor on human platelets induced by Protein A-Fc fragment complex. Also, an experimental model of intravascular coagulation following injection of staphylocci will be established to assess the role of Protein A and other toxic products in vivo in triggering intravascular coagulation and shock syndrome. Finally, we will continue our research on the problem of the interaction of staphylococci with fibrinogen, which we developed as the staphylococcal clumping test for measurement of fibrinogen and fibrin degradation products. Staphylococcal cell wall receptor for fibrinogen (clumping factor) will be isolated, purified, and characterized. The molecular mechanism of binding of fibrinogen to the staphylococcal cell wall receptor will be investigated. The results of the proposed research should generate fundamental information on the molecular mechanism of the toxic effect of gram negative bacteria and staphylococci on human cells and proteins involved in triggering blood clotting and bring about the development of new methodological approaches to measure these interactions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL030647-04
Application #
3341658
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1983-01-01
Project End
1987-03-31
Budget Start
1986-01-01
Budget End
1987-03-31
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02215
Zhang, L; Torgerson, T R; Liu, X Y et al. (1998) Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules. Proc Natl Acad Sci U S A 95:9184-9
Hawiger, J (1997) Cellular import of functional peptides to block intracellular signaling. Curr Opin Immunol 9:189-94
Liu, K Y; Timmons, S; Lin, Y Z et al. (1996) Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs. Proc Natl Acad Sci U S A 93:11819-24
Lin, Y Z; Yao, S Y; Hawiger, J (1996) Role of the nuclear localization sequence in fibroblast growth factor-1-stimulated mitogenic pathways. J Biol Chem 271:5305-8
Hawiger, J (1995) Mechanisms involved in platelet vessel wall interaction. Thromb Haemost 74:369-72
Donald, R; Ballard, D W; Hawiger, J (1995) Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators. J Biol Chem 270:9-12
Donahue, J P; Patel, H; Anderson, W F et al. (1994) Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen gamma chain obtained by carrier protein-driven crystallization. Proc Natl Acad Sci U S A 91:12178-82
Read, M A; Cordle, S R; Veach, R A et al. (1993) Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci U S A 90:9887-91
Hawiger, J; Timmons, S (1992) Binding of fibrinogen and von Willebrand factor to platelet glycoprotein IIb-IIIa complex. Methods Enzymol 215:228-43
Romano, M; Hawiger, J (1990) Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C. J Biol Chem 265:1765-70

Showing the most recent 10 out of 18 publications